Fund moves
5.4%Stake
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
APYX · NASDAQ · Surgical & Medical Instruments & Apparatus
Apyx Medical (APYX) · oqro.io/stocks/APYX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
No open-market purchase by an insider of Apyx Medical was filed in the last 90 days. The latest on record was on Mar 3, 2025.
Since 2005, Apyx Medical insiders reported 21 open-market purchases and 48 sales on Forms 4 and 5, with purchases in 10 different years, most recently 2024.
No open-market sale by an insider of Apyx Medical (APYX) was filed with the SEC in the last 90 days.
No trade in Apyx Medical (APYX) was disclosed by a member of Congress in the last 12 months.
Apyx Medical's next results are expected on Mar 8, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$2.56−0.095 (−3.58%)
Close of Nov 17, 2026, vs Nov 16 · end-of-day, not a live quote
−36.6% (−$1.48) from Nov 17, 2025 to Nov 17, 2026 · adjusted daily closes
No disclosed open-market insider trades, politician trades or fund 13F changes in this period.
Adjusted close went from $4.03 on Nov 17, 2025 to $2.56 on Nov 17, 2026 (−36.6%). Disclosed in this range: 0 insider trades, 0 pre-arranged insider sales, 0 Congress trades.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Surgical & Medical Instruments & Apparatus company based in Clearwater, Fl.
Last 12 months
−36.6%
Market value
$108M
S&P 500 +10.0% over the same dates. Prices adjusted for splits and dividends.
Short interest: 245K shares sold short (0.6% of shares outstanding), +14.8% vs the previous count, 2.1 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$14M
+9.0% vs the same quarter a year earlier
Free cash flow, last 12 months
−$8.89M
This quarter −$1.9M, a year earlier −$4.05M
Net debt
$11.7M
Debt $37.5M, cash $25.8M, at Sep 30, 2026
Net income, last 12 months
−$8.44M
Operating profit covers interest -0.6x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Nov 5, 2026.
Revenue, fiscal 2025
$52.8M
+9.9% vs the year before
Net income, fiscal 2025
−$11.2M
A loss for the year
Shares outstanding
42.1M
As of Nov 4, 2026
Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Insider buying
Traded Aug 13, 2024 · filed 202 days later
The CFO of Apyx Medical paid $6.8K out of pocket for Apyx Medical shares. Shares held went up 240% with this purchase.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
0 certified in FY2026 Q3, vs 0 a year earlier.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Against the S&P 500 over the year
Since Nov 14, 2025, APYX is down 34.5% and the index fund is up 9.0%: 43 points behind the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much APYX moves
End-of-day prices. These figures describe the past year and say nothing about what comes next.
Anyone owning more than 5% must file within days. Structured filings have existed since December 2024, so older stakes that were never amended may be missing.
Last results
Nov 5, 2026
Within the 30 days after it, until Dec 5, 2026
Next results, expected
Mar 8, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
67%
8 of 12 insider purchases since 2014 came within 30 days after a results announcement
From Apyx Medical's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Apyx Medical's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Insiders of Apyx Medical reported 21 open-market purchases and 48 sales since 2005; purchases in 10 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2024 | $6K1×1 trade | — |
| 2023 | $84K2×2 trades | $113K1×1 trade |
| 2022 | $70K2×2 trades | — |
| 2020 | $93K1×1 trade | — |
| 2016 | $299K1×1 trade | — |
| 2015 | $152K4×4 trades | — |
| 2011 | $748K6×6 trades | $19K3×3 trades |
| 2010 | — | $96K7×7 trades |
| 2009 | — | $1.61M16×16 trades |
| 2008 | $12K1×1 trade | $288K2×2 trades |
| 2007 | $41K2×2 trades | $857K11×11 trades |
| 2006 | — | $75K6×6 trades |
| 2005 | $4.5K1×1 trade | $36K2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.